Endou M, Gando S, Hattori Y, Kanno M
Department of Pharmacology, Hokkaido University School of Medicine, Sapporo, Japan.
J Pharmacol Exp Ther. 1991 Sep;258(3):992-8.
The binding profiles of the class I antiarrhythmic agents disopyramide, pirmenol and pentisomide (CM7857) to cardiac muscarinic receptors were characterized by the binding assay using [3H]-N-methyl scopolamine ([3H]NMS) as a ligand and their anti-muscarinic actions were investigated functionally in left atrial preparations. All the agents displaced the specific binding of 200 pM [3H]NMS from guinea pig left atrial membranes. Computer-assisted analysis indicated that pirmenol interacted with a single class of binding sites, but the displacement curves of disopyramide and pentisomide were shallow and best fitted to a two-site model. When the concentration of [3H]NMS was increased to 1 nM, the displacement curve of pirmenol was best fitted to a two-site model. In higher concentrations, these agents inhibited the dissociation of [3H]NMS initiated by 1 microM atropine in a concentration-dependent manner, thus revealing allosteric interactions. Two enantiomers of pirmenol possessed qualitatively the same binding properties as the racemate. In guinea pig left atria, disopyramide, pirmenol and pentisomide shifted the concentration-response curves for the negative inotropic effect of carbachol in a parallel manner. The slopes of Schild plot were not significantly different from unity, indicating that they act as a competitive antagonist of cardiac muscarinic receptors. Excellent correlation between the high affinity pKi values and the pA2 values was established for the antiarrhythmic agents. These findings suggest that disopyramide, pirmenol and pentisomide all interact with cardiac muscarinic receptors in both a competitive fashion and an allosteric one. The dual mode of the interaction with cardiac muscarinic receptors seems to be independent of their chiralities.(ABSTRACT TRUNCATED AT 250 WORDS)
Ⅰ类抗心律失常药物双异丙吡胺、吡美诺和喷替索米(CM7857)与心脏毒蕈碱受体的结合特性,采用以[3H] - N - 甲基东莨菪碱([3H]NMS)为配体的结合试验进行表征,并在左心房标本中对其抗毒蕈碱作用进行功能研究。所有药物均能使豚鼠左心房膜中200 pM [3H]NMS的特异性结合发生位移。计算机辅助分析表明,吡美诺与单一类别的结合位点相互作用,但双异丙吡胺和喷替索米的位移曲线较平缓,最适合双位点模型。当[3H]NMS浓度增加到1 nM时,吡美诺的位移曲线最适合双位点模型。在较高浓度下,这些药物以浓度依赖性方式抑制由1 μM阿托品引发的[3H]NMS解离,从而揭示变构相互作用。吡美诺的两种对映体在定性上具有与外消旋体相同的结合特性。在豚鼠左心房中,双异丙吡胺、吡美诺和喷替索米以平行方式使卡巴胆碱负性肌力作用的浓度 - 反应曲线发生位移。Schild图的斜率与1无显著差异,表明它们作为心脏毒蕈碱受体的竞争性拮抗剂起作用。抗心律失常药物的高亲和力pKi值与pA2值之间建立了良好的相关性。这些发现表明,双异丙吡胺、吡美诺和喷替索米均以竞争性和变构方式与心脏毒蕈碱受体相互作用。与心脏毒蕈碱受体相互作用的双重模式似乎与其手性无关。(摘要截短于250字)